# OA 09.02 Osimertinib Resistance Mediated by Loss of EGFR T790M Is Associated with Early Resistance and Competing Resistance Mechanisms

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/oa-09-02-osimertinib-resistance-mediated-by-loss-of-egfr-t790m-is-associated/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Geoffrey R. Oxnard,Yuebi Hu,Kathryn F. Mileham,Philip Tracy,Nora Feeney,Lynette M. Sholl,Cloud P. Paweletz,Kenneth S. Thress,Pasi A. Jänne |
| Citations | 14 |
| DOI | 10.1016/j.jtho.2017.09.376 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.jto.org/article/S1556086417311115/pdf |
| OpenAlex ID | https://openalex.org/W2767785738 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Nora Feeney](https://scholariq.org/researchers/nora-feeney/)

## Paper journal

- [Journal of Thoracic Oncology](https://scholariq.org/journals/journal-of-thoracic-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.